11 – 20 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Investigating Partially Discordant Results in Phase 3 Studies of Aducanumab
- Contribution to journal › Article
- 2022
-
Mark
Increased plasma and brain immunoglobulin A in Alzheimer’s disease is lost in apolipoprotein E ε4 carriers
- Contribution to journal › Article
-
Mark
Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease–related blood-based biomarkers : Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group
- Contribution to journal › Article
-
Mark
Developing a Porcine Model to Study the Glymphatic System
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease
- Contribution to journal › Article
-
Mark
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease : a literature review
- Contribution to journal › Scientific review
- 2021
-
Mark
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau
- Contribution to journal › Article
-
Mark
On the nature of mixed neurodegenerative amyloidopathies
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
- 2020
-
Mark
Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF
- Contribution to journal › Article
- 2018
-
Mark
Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment
- Contribution to journal › Article
